Sheet of PAYAN Nérée

Since 2022 : Research engineer, Nuclear Medicine Service, CGFL, Dijon.

2021-2022 : Post-Doctoral studies in medical imaging, Patrick G. Johnston Centre for Cancer Research, Queen’s University, Belfast, Northern Ireland, UK.

2016-2020 : PhD in instrumentation et informatique de l’image – imagerie médicale, Université de Bourgogne Franche-Comté, Dijon.

2015 : MSc Medical Physics, Université Joseph Fourier, Grenoble.

2014 : MSc1 Ingénierie pour la santé et le médicament, Université Joseph Fourier, Grenoble.

2013 : BSc in Physics, Université Joseph Fourier, Grenoble.

• Calculs dosimétriques en imagerie clinique
• Imagerie TEP dynamique et paramétrique

• Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT. Payan N, Presles B, Brunotte F, Coutant C, Desmoulins I, Vrigneaud JM, Cochet A.   2020; 47, 1103-1115. DOI: 10.1007/s00259-019-04422-4
• Critical analysis of the effect of various methodologies to compute breast cancer tumour blood flow-based texture features using first-pass 18F-FDG PET. Payan N, Presles B, Truntzer C, Courcet E, Coutant C, Desmoulins I, Brunotte F, Vrigneaud JM, Cochet A. Physica Medica. 2022; 103, 98-107. DOI: 10.1016/j.ejmp.2022.09.015
• Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer. Payan N, Presles B, Coutant C, Desmoulins I, Ladoire S, Beltjens F, Brunotte F, Vrigneaud JM, Cochet A. EJNMMI Res. 2024; 14:60. DOI: 10.1186/s13550-024-01115-4

• Diagnostic ⁶⁸Ga-PSMA-11 PET/CT image-based dosimetry: a better estimate of ¹⁷⁷Lu-PSMA-617 therapy absorbed dose than PET uptake metrics. Payan N, Drouet C., Jougla A., Cochet A., Vrigneaud J-M. Annual Congress of the European Association of Nuclear Medicine, Barcelona, European Journal of Nuclear Medicine and Molecular Imaging, 2025.
• Comparison of SUV and tumour net uptake rate values using dynamic whole-body ⁶⁸Ga-PSMA-11 PET/CT in patients with metastatic castrate-resistant prostate cancer. Payan N., Vrigneaud J-M., Cochet A., Annual Congress of the European Association of Nuclear Medicine, Vienna, European Journal of Nuclear Medicine and Molecular Imaging, 2023.
• Contribution of tumour blood-flow for prediction of response to neoadjuvant chemotherapy in breast cancer using 18F-FDG PET/CT. Payan N., Presles B., Vrigneaud J-M., Cochet A. Annual Congress of the European Association of Nuclear Medicine, Barcelona, European Journal of Nuclear Medicine and Molecular Imaging, Dusseldorf, 2019.
• Texture analysis of tumour metabolism and perfusion for newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT. Payan N., Presles B., Vrigneaud J-M., Cochet A. Annual Congress of the European Association of Nuclear Medicine, Barcelona, European Journal of Nuclear Medicine and Molecular Imaging, Barcelona, 2018.